| Financial Year |
March 31 2023 |
| Monetary Funds |
144,177,355.47 |
| Held-for-trading Financial Assets |
132,710,281.74 |
| Notes Receivable |
360,868.02 |
| Accounts Receivable |
195,412,975.46 |
| Advances to Suppliers |
2,102,862.25 |
| Other Receivables |
11,709,086.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,938,721.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
21,811,256.94 |
| Other Current Assets |
3,011,597.89 |
| Total Current Assets |
585,803,509.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,237,912.41 |
| Investment Properties |
-- |
| Fixed Assetes |
124,400,427.01 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,504,683.04 |
| R&D expenses |
279,839.87 |
| Goodwill |
19,705,081.19 |
| Long-Term Deferred and Prepaid Expenses |
6,614,106.63 |
| Deferred Income Tax Assets |
6,191,317.24 |
| Other Non-Current Assets |
50,000,000.00 |
| Sub-Total of Non-Current Assets |
352,774,254.57 |
| Total Assets |
938,577,764.08 |
| Short-Term Loans |
1,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
64,872,852.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,317,552.28 |
| Taxes Payable |
4,009,284.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,652,608.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,584,941.69 |
| Other Current Liabilities |
12,670,399.70 |
| Sub-Total of Current Liabilities |
133,204,683.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,882,864.01 |
| Deferred Income Tax Liabilities |
407,466.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,798,273.31 |
| Total Liabilities |
138,002,957.03 |
| Paid-In Capital(Or Share Stock) |
104,000,000.00 |
| Capital Surplus |
388,953,441.53 |
| Surplus Reserve |
53,258,290.61 |
| LESS:Treasury Stock |
40,237,901.77 |
| Undistributed Profits |
289,601,621.49 |
| Minority Stockholder's Interest |
5,739,324.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
794,835,482.49 |
| Owner's Equity（Stockholder's Equity） |
800,574,807.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
938,577,764.08 |
